Applied Psychophysiology and Biofeedback

, Volume 29, Issue 4, pp 233–243 | Cite as

The Effectiveness of Neurofeedback and Stimulant Drugs in Treating AD/HD: Part II. Replication

Article

This study replicated T. R. Rossiter and T. J. La Vaque (1995) with a larger sample, expanded age range, and improved statistical analysis. Thirty-one AD/HD patients who chose stimulant drug (MED) treatment were matched with 31 patients who chose a neurofeedback (EEG) treatment program. EEG patients received either office (n = 14) or home (n = 17) neurofeedback. Stimulants for MED patients were titrated using the Test of Variables of Attention (TOVA). EEG (effect size [ES] = 1.01–1.71) and MED (ES = 0.80–1.80) groups showed statistically and clinically significant improvement on TOVA measures of attention, impulse control, processing speed, and variability in attention. The EEG group demonstrated statistically and clinically significant improvement on behavioral measures (Behavior Assessment System for Children, ES = 1.16–1.78, and Brown Attention Deficit Disorder Scales, ES = 1.59). TOVA gain scores for the EEG and MED groups were not significantly different. More importantly, confidence interval and nonequivalence null hypothesis testing confirmed that the neurofeedback program produced patient outcomes equivalent to those obtained with stimulant drugs. An effectiveness research design places some limitations on the conclusions that can be drawn.

neurofeedback EEG biofeedback AD/HD stimulant drugs active treatment control 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association. (1994). Diagnostic and statistical maual of mental disorders (4th ed.). Washington, DC: Author.Google Scholar
  2. Anderson, S., & Hauck, W. W. (1983). A new procedure for testing equivalence in comparative bioavailability and other clinical trials. Communications in Statistics—Theory and Methods, 12, 2663–2692.Google Scholar
  3. Barkley, R. A. (1990). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guilford Press.Google Scholar
  4. Brown, T. E. (1996). Brown Attention-Deficit Disorder Scales. San Antonio, TX: Psychological Corporation.Google Scholar
  5. Clarke, G. N. (1995). Improving the transition from basic efficacy research to effectiveness studies: Methodological issues and procedures. Journal of Consulting and Clinical Psychology, 63, 718–725.PubMedGoogle Scholar
  6. DuPaul, G. J., Barkley, R. A., & Connor, D. E. (1998). Stimulants. In R. A. Barkley (Ed.), Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (2nd ed., pp. 263–293). New York: Guilford Press.Google Scholar
  7. Firestone, P. (1982). Factors associated with children’s adherence to stimulant medication. American Journal of Orthopsychiatry, 52(3), 447–457.CrossRefPubMedGoogle Scholar
  8. Fuchs, T., Birbaumer, N., Lutzenberger, W., Gruzelier, J. H., & Kaiser, J. (2003). Neurofeedback treatment for attention-deficit/hyperactivty disorder in children: A comparison with methylphenidate. Applied Psychophysiology and Biofeedback, 28(1), 1–12.PubMedGoogle Scholar
  9. Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12–19.PubMedGoogle Scholar
  10. Kaufman, A., & Kaufman, N. (1990). Kaufman Brief Intelligence Test. Circle Pines, MN: AGS Publishing.Google Scholar
  11. Kazdin, A. E. (2003). Research design in clinical psychology (4th ed.). Boston: Allyn and Bacon.Google Scholar
  12. Leark, R. A., Dupuy, T. R., Greenberg, L. M., Corman, C. L., & Kindschi, C. L. (1996). Test of Variables of Attention Professional Manual Version 7.0. Available from Universal Attention Disorders, 4281 Katella, Suite 215, Los Alamitos, CA 90720.Google Scholar
  13. Lubar, J. F., & Shouse, M. N. (1976). EEG and behavioral changes in a hyperkinetic child concurrent with training of the sensorimotor rhythm (SMR): A preliminary report. Biofeedback and Self-Regulation, 3, 293–306.Google Scholar
  14. Monastra, V. J., Monastra, D. M., & George, S. (2002). The effects of stimulant therapy, EEG biofeedback, and parenting style on the primary symptoms of attention-deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback, 27(4), 231–249.PubMedGoogle Scholar
  15. Poly Software International. (2002). ProStat Version 3 (Computer software). Pearl River, NY.Google Scholar
  16. Reynolds, C. R., & Kamphaus, R. W. (1992). Behavior Assessment System for Children manual. Available from American Guidance Service, 4201 Woodland Road, Circle Pines, MN 55014.Google Scholar
  17. Riccio, C. A., Reynolds, C. R., & Lowe, P. A. (2001). Clinical applications of continuous performance tests: Measuring attention and impulsive responding in children and adults. New York: Wiley.Google Scholar
  18. Rossiter, T. R. (1998). Patient directed neurofeedback for AD/HD. Journal of Neurotherapy, 2, 54–64.Google Scholar
  19. Rossiter, T. R. (2002). Neurofeedback for AD/HD: A ratio feedback case study and tutorial. Journal of Neurotherapy, 6, 9–35.Google Scholar
  20. Rossiter, T. R. (2004). The effectiveness of neurofeedback and stimulant drugs in treating AD/HD: Part I. review of methodological issues. Applied Psychophysiology and Biofeedback, 29, 95–112.PubMedGoogle Scholar
  21. Rossiter, T. R., & La Vaque, T. J. (1995). A comparison of EEG biofeedback and psychostimulants in treating attention deficit hyperactivity disorders. Journal of Neurotherapy, 1, 48–59.Google Scholar
  22. Schachter, H., Pham, B., King, J., Langford, S., & Moher, D. (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal, 165, 1475–1488.PubMedGoogle Scholar
  23. Schuirmann, D. J. (1987). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmaceutics, 15, 657–680.PubMedGoogle Scholar
  24. Stevens, J. S. (2002). Applied multivariate statistics for the social sciences (4th ed.). Mahwah, NJ: Lawrence Erlbaum.Google Scholar
  25. Stevens, J. S. (1999). Intermediate statistics: A modern approach (2nd ed.). Mahwah, NJ: Lawrence Erlbaum.Google Scholar
  26. Westlake, W. J. (1981). Bioequivalence testing—A need to rethink. Biometrics, 37, 591–593.Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2004

Authors and Affiliations

  1. 1.De Pere

Personalised recommendations